117 related articles for article (PubMed ID: 8007690)
1. Biomarkers in early breast neoplasia.
Allred DC; O'Connell P; Fuqua SA
J Cell Biochem Suppl; 1993; 17G():125-31. PubMed ID: 8007690
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical studies of early breast cancer evolution.
Allred DC; O'Connell P; Fuqua SA; Osborne CK
Breast Cancer Res Treat; 1994; 32(1):13-8. PubMed ID: 7819582
[TBL] [Abstract][Full Text] [Related]
3. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic studies of early breast cancer evolution.
O'Connell P; Pekkel V; Fuqua S; Osborne CK; Allred DC
Breast Cancer Res Treat; 1994; 32(1):5-12. PubMed ID: 7819586
[TBL] [Abstract][Full Text] [Related]
5. Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer.
Coene ED; Schelfhout V; Winkler RA; Schelfhout AM; Van Roy N; Grooteclaes M; Speleman F; De Potter CR
Virchows Arch; 1997 May; 430(5):365-72. PubMed ID: 9174626
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Sasano H
Jpn J Cancer Res; 2000 Nov; 91(11):1169-76. PubMed ID: 11092983
[TBL] [Abstract][Full Text] [Related]
7. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.
O'Connell P; Pekkel V; Fuqua SA; Osborne CK; Clark GM; Allred DC
J Natl Cancer Inst; 1998 May; 90(9):697-703. PubMed ID: 9586667
[TBL] [Abstract][Full Text] [Related]
8. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
Done SJ; Arneson NC; Ozçelik H; Redston M; Andrulis IL
Cancer Res; 1998 Feb; 58(4):785-9. PubMed ID: 9485035
[TBL] [Abstract][Full Text] [Related]
9. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
10. HER2 as a prognostic factor in breast cancer.
Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
[TBL] [Abstract][Full Text] [Related]
11. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS
J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068
[TBL] [Abstract][Full Text] [Related]
12. bcl-2 expression in the spectrum of preinvasive breast lesions.
Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.
Larson PS; de las Morenas A; Cerda SR; Bennett SR; Cupples LA; Rosenberg CL
J Pathol; 2006 Jul; 209(3):307-16. PubMed ID: 16604511
[TBL] [Abstract][Full Text] [Related]
14. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal alterations in pure nonneoplastic breast lesions: implications for breast cancer progression.
Ellsworth RE; Ellsworth DL; Weyandt JD; Fantacone-Campbell JL; Deyarmin B; Hooke JA; Shriver CD
Ann Surg Oncol; 2010 Jun; 17(6):1688-94. PubMed ID: 20107913
[TBL] [Abstract][Full Text] [Related]
16. Nuclear cytometric changes in breast carcinogenesis.
Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
[TBL] [Abstract][Full Text] [Related]
17. Analysis of p53 mutations in cells taken from paraffin-embedded tissue sections of ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
Keohavong P; Gao WM; Mady HH; Kanbour-Shakir A; Melhem MF
Cancer Lett; 2004 Aug; 212(1):121-30. PubMed ID: 15246568
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer.
Verschuur-Maes AH; de Bruin PC; van Diest PJ
Breast Cancer Res Treat; 2012 Dec; 136(3):705-15. PubMed ID: 23104224
[TBL] [Abstract][Full Text] [Related]
19. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
[TBL] [Abstract][Full Text] [Related]
20. Genetic mutations and expression of p53 in non-invasive breast lesions.
Mao X; Fan C; Wei J; Yao F; Jin F
Mol Med Rep; 2010; 3(6):929-34. PubMed ID: 21472335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
